How Temperature Monitoring Is Transforming the Biopharmaceutical Third-Party Logistics Market
The global biopharmaceutical third-party logistics market was valued at USD 152.0 billion in 2025 and is projected to increase from USD 161.4 billion in 2026 to USD 258.4 billion by 2033 , registering a CAGR of 6.9% from 2026 to 2033 . North America dominated the market in 2025, accounting for a revenue share of 41.7% . Market growth is primarily driven by the expanding commercialization of biologics and biosimilars, increasing demand for temperature-controlled and Good Distribution Practice (GDP)-compliant logistics infrastructure, and rising outsourcing of pharmaceutical supply chain operations. Additionally, the growth of clinical trials and advanced therapies, including cell and gene therapies, and the adoption of digital supply chain technologies are strengthening demand for specialized logistics services. Biopharmaceutical Third-Party Logistics Market Overview According to Grand View Research, the global biopharmaceutical third-party logistics market is expected to experience s...